Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Polman

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Neurology|March 23, 2005
Treatment with laquinimod reduces development of active MRI lesions in relapsing MSC Polman, F Barkhof, M Sandberg-Wollheim, et al.
Neurology|September 13, 2006
Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosisP J Young, C Lederer, K Eder, et al.
The Cochrane Database of Systematic Reviews|November 1, 2001
Interferon in relapsing-remitting multiple sclerosisG P Rice, B Incorvaia, L Munari, et al.
International Journal of Sports Medicine|May 27, 2009
Relative torque profiles of elite male youth footballers: effects of age and pubertal developmentH Forbes, A Bullers, A Lovell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized studyC Polman, F Barkhof, L Kappos, et al.
Journal of Neurology|August 27, 1999
Exploring differences between subgroups of multiple sclerosis patients in health-related quality of lifeL Pfennings, L Cohen, H Adèr, et al.
Journal of Aging and Physical Activity|March 12, 2016
An Acute Bout of Exercise Improves the Cognitive Performance of Older AdultsLiam Johnson, Patricia K Addamo, Isaac Selva Raj, et al.
Neurology|November 24, 2004
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trialsL Kappos, B Weinshenker, C Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Towards a european network for multiple sclerosis trials (ENMST)L Kappos, C Polman, A J Thompson, et al.
The British Journal of Medical Psychology|April 30, 1998
Psychological functioning in primary progressive versus secondary progressive multiple sclerosisL Vleugels, L Pfennings, F Pouwer, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Neurology|March 23, 2005
Treatment with laquinimod reduces development of active MRI lesions in relapsing MSC Polman, F Barkhof, M Sandberg-Wollheim, et al.
Neurology|September 13, 2006
Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosisP J Young, C Lederer, K Eder, et al.
The Cochrane Database of Systematic Reviews|November 1, 2001
Interferon in relapsing-remitting multiple sclerosisG P Rice, B Incorvaia, L Munari, et al.
International Journal of Sports Medicine|May 27, 2009
Relative torque profiles of elite male youth footballers: effects of age and pubertal developmentH Forbes, A Bullers, A Lovell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized studyC Polman, F Barkhof, L Kappos, et al.
Journal of Neurology|August 27, 1999
Exploring differences between subgroups of multiple sclerosis patients in health-related quality of lifeL Pfennings, L Cohen, H Adèr, et al.
Journal of Aging and Physical Activity|March 12, 2016
An Acute Bout of Exercise Improves the Cognitive Performance of Older AdultsLiam Johnson, Patricia K Addamo, Isaac Selva Raj, et al.
Neurology|November 24, 2004
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trialsL Kappos, B Weinshenker, C Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Towards a european network for multiple sclerosis trials (ENMST)L Kappos, C Polman, A J Thompson, et al.
The British Journal of Medical Psychology|April 30, 1998
Psychological functioning in primary progressive versus secondary progressive multiple sclerosisL Vleugels, L Pfennings, F Pouwer, et al.
Pageof 5